» Authors » Marc A Riedl

Marc A Riedl

Explore the profile of Marc A Riedl including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 103
Citations 1342
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Christiansen S, Banerji A, Bernstein J, Busse P, Craig T, Li H, et al.
J Allergy Clin Immunol Pract . 2025 Mar; PMID: 40057189
Hereditary angioedema with normal C1 inhibitor (HAE-nl-C1INH) was initially described almost a quarter century ago. Considerable progress towards unraveling the mysteries of this complex disease has been made during the...
2.
Zuraw B, Bork K, Bouillet L, Christiansen S, Farkas H, Germenis A, et al.
Clin Rev Allergy Immunol . 2025 Mar; 68(1):24. PMID: 40053270
Hereditary angioedema (HAE) has been recognized for almost 150 years. The newest form of HAE, where C1 inhibitor levels are normal (HAE-nC1INH), was first described in 2000. Over the last...
3.
Craig T, Baptist A, Anderson J, Zaragoza-Urdaz R, Burnette A, Kelbel T, et al.
Ann Allergy Asthma Immunol . 2025 Jan; PMID: 39842773
Background: Hereditary angioedema (HAE) is a rare disorder in which unpredictable angioedema attacks significantly affect patient quality of life. Information on patient experiences and perspectives of HAE management within underrepresented...
4.
Cohn D, Soteres D, Craig T, Lumry W, Magerl M, Riedl M, et al.
J Allergy Clin Immunol . 2024 Dec; 155(3):726-739. PMID: 39724968
Over the past 2 decades, guidelines for the on-demand treatment of hereditary angioedema attacks have undergone significant evolution. Early treatment guidelines, such as the Canadian 2003 International Consensus Algorithm, often...
5.
Riedl M, Patil D, Rodrigues J, Kuruvilla M, Raftery T, Pivneva I, et al.
Ann Allergy Asthma Immunol . 2024 Dec; 134(3):324-332.e4. PMID: 39694087
Background: Chronic spontaneous urticaria (CSU) is an unpredictable inflammatory skin condition with substantial clinical burden that affects 0.23% to 0.78% of the US population. Objective: To describe the incidence and...
6.
Castaldo A, Siersbaek N, Corcoran D, Selva C, Jervelund C, Christiansen S, et al.
Ann Allergy Asthma Immunol . 2024 Jul; 133(6):703-711.e6. PMID: 39038704
Background: Hereditary angioedema (HAE) attacks are unpredictable, cause a substantial and enduring burden of illness, and are potentially fatal. Because of issues unique to the US health care system, there...
7.
Do T, Riedl M
Immunol Allergy Clin North Am . 2024 Jun; 44(3):561-576. PMID: 38937016
Angioedema is characterized by transient movement of fluid from the vasculature into the interstitial space leading to subcutaneous or submucosal non-pitting edema. Current evidence suggests that most angioedema conditions can...
8.
Riedl M, Farkas H, Aygoren-Pursun E, Psarros F, Soteres D, Staevska M, et al.
N Engl J Med . 2024 May; 391(1):32-43. PMID: 38819658
Background: Approved on-demand treatments for hereditary angioedema attacks need to be administered parenterally, a route of administration that is associated with delays in treatment or withholding of therapy. Methods: In...
9.
Riedl M, Tachdjian R, Lumry W, Craig T, Karakaya G, Gelincik A, et al.
N Engl J Med . 2024 May; 391(1):21-31. PMID: 38819395
Background: Hereditary angioedema is a rare disorder characterized by episodic, potentially life-threatening swelling caused by kallikrein-kinin dysregulation. Long-term prophylaxis can stabilize this system. Donidalorsen, an antisense oligonucleotide, specifically reduces prekallikrein...
10.
Smith T, Riedl M
Ann Allergy Asthma Immunol . 2024 Apr; 133(4):380-390. PMID: 38679158
Hereditary angioedema (HAE) is a rare genetic condition causing unpredictable and severe episodes of angioedema that are debilitating and life-threatening. Moreover, HAE can be classified into HAE due to C1-esterase...